Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation

Por Stokol, Tracy, Serpa, Priscila B. S., Zahid, Muhammad N., Brooks, Marjory B.
Publicado no Front Vet Sci (2016)

Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Acti...

Por Stokol, Tracy, Serpa, Priscila B. S., Zahid, Muhammad N., Brooks, Marjory B.
Publicado no Front Vet Sci (2017)

Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies

Por Dhillon, Simrat, Witteveldt, Jeroen, Gatherer, Derek, Owsianka, Ania M., Zeisel, Mirjam B., Zahid, Muhammad N., Rychłowska, Małgorzata, Foung, Steven K. H., Baumert, Thomas F., Angus, Allan G. N., Patel, Arvind H.
Publicado em 2010

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Por Lupberger, Joachim, Zeisel, Mirjam B., Xiao, Fei, Thumann, Christine, Fofana, Isabel, Zona, Laetitia, Davis, Christopher, Mee, Christopher J., Turek, Marine, Gorke, Sebastian, Royer, Cathy, Fischer, Benoit, Zahid, Muhammad N., Lavillette, Dimitri, Fresquet, Judith, Cosset, François-Loïc, Rothenberg, S Michael, Pietschmann, Thomas, Patel, Arvind H., Pessaux, Patrick, Doffoël, Michel, Raffelsberger, Wolfgang, Poch, Olivier, Mckeating, Jane A., Brino, Laurent, Baumert, Thomas F.
Publicado em 2011